International Stem Cell Corporation (ISCO)
OTCMKTS
· Delayed Price · Currency is USD
0.170
+0.020 (13.33%)
Apr 28, 2026, 4:00 PM EST
International Stem Cell Revenue
In the year 2025, International Stem Cell had annual revenue of $9.10M with 0.17% growth. International Stem Cell had revenue of $2.16M in the quarter ending December 31, 2025, a decrease of -11.90%.
Revenue
9.10M
Revenue Growth
+0.17%
P/S Ratio
0.15
Revenue / Employee
275.76K
Employees
33
Market Cap
1.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.10M | 15.00K | 0.17% |
| Dec 31, 2024 | 9.09M | 1.30M | 16.64% |
| Dec 31, 2023 | 7.79M | -391.00K | -4.78% |
| Dec 31, 2022 | 8.18M | 1.00M | 13.99% |
| Dec 31, 2021 | 7.18M | 48.00K | 0.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evofem Biosciences | 20.18M |
| Eastgate Biotech | 137.64K |
| LakeShore Biopharma | 84.75M |
| Iterum Therapeutics | 390.00K |
| Lyra Therapeutics | 398.00K |
International Stem Cell News
- 1 year ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 2 years ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 4 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire